Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease

Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated:  12/31/1969
University of Alabama
mi
from
Birmingham, AL
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated: 12/31/1969
University of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated:  12/31/1969
University of Florida
mi
from
Jacksonville, FL
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated: 12/31/1969
University of Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated:  12/31/1969
Advocate Good Samaritan
mi
from
Downers Grove, IL
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated: 12/31/1969
Advocate Good Samaritan
mi
from
Downers Grove, IL
Click here to add this to my saved trials
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated:  12/31/1969
Advocate Health
mi
from
Naperville, IL
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated: 12/31/1969
Advocate Health
mi
from
Naperville, IL
Click here to add this to my saved trials
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated:  12/31/1969
University of Massachusetts
mi
from
Worcester, MA
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated: 12/31/1969
University of Massachusetts
mi
from
Worcester, MA
Click here to add this to my saved trials
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated:  12/31/1969
Columbia University
mi
from
New York, NY
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated: 12/31/1969
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated:  12/31/1969
Rex Hospital, Inc
mi
from
Raleigh, NC
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated: 12/31/1969
Rex Hospital, Inc
mi
from
Raleigh, NC
Click here to add this to my saved trials
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated:  12/31/1969
St. John Research Institute
mi
from
Bartlesville, OK
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated: 12/31/1969
St. John Research Institute
mi
from
Bartlesville, OK
Click here to add this to my saved trials
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh
mi
from
Pittsburgh, PA
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated:  12/31/1969
Torrance Medical Center
mi
from
Torrance, CA
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated: 12/31/1969
Torrance Medical Center
mi
from
Torrance, CA
Click here to add this to my saved trials
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated:  12/31/1969
Clearwater Cardiovascular
mi
from
Clearwater, FL
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated: 12/31/1969
Clearwater Cardiovascular
mi
from
Clearwater, FL
Click here to add this to my saved trials
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University
mi
from
Baltimore, MD
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated:  12/31/1969
Northern Michigan Hospital
mi
from
Petoskey, MI
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated: 12/31/1969
Northern Michigan Hospital
mi
from
Petoskey, MI
Click here to add this to my saved trials
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated:  12/31/1969
Abbott Northwestern
mi
from
Minneapolis, MN
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated: 12/31/1969
Abbott Northwestern
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated:  12/31/1969
North Mississippi Medical Center
mi
from
Tupelo, MS
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated: 12/31/1969
North Mississippi Medical Center
mi
from
Tupelo, MS
Click here to add this to my saved trials
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated:  12/31/1969
St. Joseph Medical Center
mi
from
Saint Charles, MO
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated: 12/31/1969
St. Joseph Medical Center
mi
from
Saint Charles, MO
Click here to add this to my saved trials
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated:  12/31/1969
Mount Sinai Hospital
mi
from
New York, NY
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated: 12/31/1969
Mount Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated:  12/31/1969
Austin Heart Central
mi
from
Austin, TX
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated: 12/31/1969
Austin Heart Central
mi
from
Austin, TX
Click here to add this to my saved trials
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated:  12/31/1969
Baylor Scott & White
mi
from
Plano, TX
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated: 12/31/1969
Baylor Scott & White
mi
from
Plano, TX
Click here to add this to my saved trials
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated:  12/31/1969
Austin Heart Round Rock
mi
from
Round Rock, TX
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated: 12/31/1969
Austin Heart Round Rock
mi
from
Round Rock, TX
Click here to add this to my saved trials
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated:  12/31/1969
MedStar Washington Hospital Center
mi
from
Washington,
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated: 12/31/1969
MedStar Washington Hospital Center
mi
from
Washington,
Click here to add this to my saved trials
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated:  12/31/1969
Montefiore Medical Center
mi
from
New York, NY
Evaluation of RenalGuard® System to Reduce the Incidence of Contrast Induced Nephropathy in At-Risk Patients
A Study to Evaluate RenalGuard® System Safety & Efficacy When Compared With Standard Care in the Prevention of Contrast Induced NephRopathy in the SettinG of a Catheterization Laboratory
Status: Enrolling
Updated: 12/31/1969
Montefiore Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Exercise Trial in Chronic Kidney Disease
Randomized Trial of Aerobic Exercise Training on Cognitive and Physical Function in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Baltimore VA Medical Center / University of Maryland Medical Center
mi
from
Baltimore, MD
Exercise Trial in Chronic Kidney Disease
Randomized Trial of Aerobic Exercise Training on Cognitive and Physical Function in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Baltimore VA Medical Center / University of Maryland Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Exercise Trial in Chronic Kidney Disease
Randomized Trial of Aerobic Exercise Training on Cognitive and Physical Function in Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Tufts Medical Center
mi
from
Boston, MA
Exercise Trial in Chronic Kidney Disease
Randomized Trial of Aerobic Exercise Training on Cognitive and Physical Function in Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
Southern Arizona VA Health Care System, Tucson
mi
from
Tucson, AZ
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
Southern Arizona VA Health Care System, Tucson
mi
from
Tucson, AZ
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
Central Arkansas VHS John L. McClellan Memorial Veterans Hospital, Little Rock, AR
mi
from
Little Rock, AR
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
Central Arkansas VHS John L. McClellan Memorial Veterans Hospital, Little Rock, AR
mi
from
Little Rock, AR
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
VA Palo Alto Health Care System, Palo Alto, CA
mi
from
Palo Alto, CA
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
VA Palo Alto Health Care System, Palo Alto, CA
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
San Francisco VA Medical Center, San Francisco, CA
mi
from
San Francisco, CA
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
San Francisco VA Medical Center, San Francisco, CA
mi
from
San Francisco, CA
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
mi
from
West Los Angeles, CA
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
VA Greater Los Angeles Healthcare System, West Los Angeles, CA
mi
from
West Los Angeles, CA
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
Bay Pines VA Healthcare System, Pay Pines, FL
mi
from
Bay Pines, FL
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
Bay Pines VA Healthcare System, Pay Pines, FL
mi
from
Bay Pines, FL
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
North Florida/South Georgia Veterans Health System, Gainesville, FL
mi
from
Gainesville, FL
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
North Florida/South Georgia Veterans Health System, Gainesville, FL
mi
from
Gainesville, FL
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
Charlie Norwood VA Medical Center, Augusta, GA
mi
from
Augusta, GA
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
Charlie Norwood VA Medical Center, Augusta, GA
mi
from
Augusta, GA
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
Atlanta VA Medical and Rehab Center, Decatur, GA
mi
from
Decatur, GA
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
Atlanta VA Medical and Rehab Center, Decatur, GA
mi
from
Decatur, GA
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
Jesse Brown VA Medical Center, Chicago, IL
mi
from
Chicago, IL
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
Jesse Brown VA Medical Center, Chicago, IL
mi
from
Chicago, IL
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
Richard L. Roudebush VA Medical Center, Indianapolis, IN
mi
from
Indianapolis, IN
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
Richard L. Roudebush VA Medical Center, Indianapolis, IN
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
VA Boston Healthcare System West Roxbury Campus, West Roxbury, MA
mi
from
West Roxbury, MA
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
VA Boston Healthcare System West Roxbury Campus, West Roxbury, MA
mi
from
West Roxbury, MA
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
VA Ann Arbor Healthcare System, Ann Arbor, MI
mi
from
Ann Arbor, MI
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
VA Ann Arbor Healthcare System, Ann Arbor, MI
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
Minneapolis VA Health Care System, Minneapolis, MN
mi
from
Minneapolis, MN
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
Minneapolis VA Health Care System, Minneapolis, MN
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
Kansas City VA Medical Center, Kansas City, MO
mi
from
Kansas City, MO
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
Kansas City VA Medical Center, Kansas City, MO
mi
from
Kansas City, MO
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
New Mexico VA Health Care System, Albuquerque, NM
mi
from
Albuquerque, NM
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
New Mexico VA Health Care System, Albuquerque, NM
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
VA Western New York Healthcare System, Buffalo, NY
mi
from
Buffalo, NY
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
VA Western New York Healthcare System, Buffalo, NY
mi
from
Buffalo, NY
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY
mi
from
New York, NY
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY
mi
from
New York, NY
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
Durham VA Medical Center, Durham, NC
mi
from
Durham, NC
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
Durham VA Medical Center, Durham, NC
mi
from
Durham, NC
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
Cincinnati VA Medical Center, Cincinnati, OH
mi
from
Cincinnati, OH
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
Cincinnati VA Medical Center, Cincinnati, OH
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
Louis Stokes VA Medical Center, Cleveland, OH
mi
from
Cleveland, OH
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
Louis Stokes VA Medical Center, Cleveland, OH
mi
from
Cleveland, OH
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
Dayton VA Medical Center, Dayton, OH
mi
from
Dayton, OH
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
Dayton VA Medical Center, Dayton, OH
mi
from
Dayton, OH
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
Oklahoma City VA Medical Center, Oklahoma City, OK
mi
from
Oklahoma City, OK
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
Oklahoma City VA Medical Center, Oklahoma City, OK
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
Portland VA Medical Center, Portland, OR
mi
from
Portland, OR
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
Portland VA Medical Center, Portland, OR
mi
from
Portland, OR
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA
mi
from
Pittsburgh, PA
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated:  12/31/1969
Ralph H. Johnson VA Medical Center, Charleston, SC
mi
from
Charleston, SC
Prevention of Serious Adverse Events Following Angiography
CSP #578 - Prevention of Serious Adverse Events Following Angiography (PRESERVE)
Status: Enrolling
Updated: 12/31/1969
Ralph H. Johnson VA Medical Center, Charleston, SC
mi
from
Charleston, SC
Click here to add this to my saved trials